Does Obesity Need a New Name?

Does Obesity Need a New Name?

The American Association of Clinical Endocrinologists and the American College of Endocrinology are seeking to eliminate the stigma surrounding the term "obesity" and clarify information about obesity as a disease state.

Importance of the "Wow" Factor

Importance of the "Wow" Factor

The natural curiosity provoked by looking at research and clinical care with a sense of wonder may help us find new ways to deal with old problems.

Q&A: How to Maximize Practice Revenues

Q&A: How to Maximize Practice Revenues

Keeping abreast of changing payment models and regulations is key to maximizing your practice's finances.

Q&A: Opting Out of Medicare

Q&A: Opting Out of Medicare

Katherine A. Roberts, MD, FACE, ECNU, discusses her experience with opting out of Medicare and offers advice to physicians considering doing the same.

VARIATION Study: Investigator Insights

VARIATION Study: Investigator Insights

Harpreet Bajaj, MD, MPH, ECNU, FACE, offers perspective on his study of various insulin regimens in type 2 diabetes.

What’s Stopping Your Patients?

What’s Stopping Your Patients?

In addition to financial and time barriers, patients encounter an array of problems that interfere with their achieving optimal control of their diabetes.

Lifestyle Changes: Great Intentions...

Lifestyle Changes: Great Intentions...

Several strategies may help patients incorporate lifestyle changes into their daily lives.

The 'Artificial Pancreas' Has Arrived

The 'Artificial Pancreas' Has Arrived

FDA approval of the first closed-loop insulin delivery system is exciting for both physicians and patients. What does this mean for the future?

Future of Diabetes: Academic and Community Physicians

Future of Diabetes: Academic and Community Physicians

How can we encourage academic and community physicians to fill gaps in health care?

Role of Technology in Diabetes Care

Role of Technology in Diabetes Care

Edward C. Chao, DO, highlights important considerations for developing technology for diabetes management.

Importance of DSME in Type 2 Diabetes

Importance of DSME in Type 2 Diabetes

Joan K. Bardsley, MBA, RN, CDE, describes a joint position statement regarding implementation of diabetes self-management education.

Tackling Obesity

Tackling Obesity

Diabetes educators can help patients with obesity achieve long-term weight loss and prevent gaining it back.

Diabetes Educators as Care Coordinators

Diabetes Educators as Care Coordinators

The Holy Grail of health care is delivery of quality care at a reduced cost. But what exactly is quality care? How do we really know we are cutting costs?

Need for Change in the Health Care Environment

Need for Change in the Health Care Environment

Joan K. Bardsley, MBA, RN, CDE, FAADE, offers her perspective on the current state of health care and what needs to change.

AADE16: Embracing Change in Diabetes Education

AADE16: Embracing Change in Diabetes Education

Joan K. Bardsley, MBA, RN, CDE, discusses the theme of this year's annual meeting of the Association of Diabetes Educators.

Sustaining Adherence in Diabetes

Sustaining Adherence in Diabetes

What tools or techniques can we offer our patients to facilitate starting and sustaining adherence?

Barriers to Preventing Diabetes

Barriers to Preventing Diabetes

A change in how patients and physicians view diabetes may is necessary for preventing the disease and its complications.

Can We Learn From Our Toughest Patients?

Can We Learn From Our Toughest Patients?

Sometimes the most frustrating patients, the so-called "non-adherent" ones, can teach us how to improve diabetes care.

Health Care Workplace Violence Significantly Underreported

Health Care Workplace Violence Significantly Underreported

Data show that only 26% of physicians and 30% of nurses report episodes of workplace violence.

SGLT2 Inhibitors: A Class Effect?

SGLT2 Inhibitors: A Class Effect?

Data on cardiovascular benefits as well as adverse effects have thrust this class of diabetes drugs into the spotlight.

From Idea to Innovation in Diabetes

From Idea to Innovation in Diabetes

Researchers and clinicians must work to adopt strategies to integrate findings from clinical research into patient care.

Challenges of Wearable Medical Devices

Challenges of Wearable Medical Devices

The explosion of technological advances in the medical field poses challenges, including cybersecurity and potentially new malpractice claims.

Conversation Maps and Diabetes Education

Conversation Maps and Diabetes Education

The Conversation Map tools help incorporate guidelines to help clinicians individualize diabetes management.

DSME Necessary for Diabetes Management

DSME Necessary for Diabetes Management

Diabetes self-management education is an important aspect of diabetes care, and clinicians need to increase its use.

Flourishing with Diabetes

Flourishing with Diabetes

Focusing on what the patient does right is most beneficial in diabetes management.

Joint Position Statement on DSME

Joint Position Statement on DSME

AADE, ADA and AND released position statement on when a patient should be referred for diabetes self-management education.

DSME Improves Glycemic Control

DSME Improves Glycemic Control

A systematic review of evidence may help answer question of whether DSME benefits patients with diabetes.

Bioidentical Hormone Therapy for Menopause

Bioidentical Hormone Therapy for Menopause

Women seeking relief from menopausal symptoms must be aware of the risks, benefits of different treatment options.

National DPP Offers Model for Fighting Diabetes

National DPP Offers Model for Fighting Diabetes

Ann Albright, RD, PhD, of the CDC, discusses components of the National DPP.

Role of Connected Health Technology

Role of Connected Health Technology

Embracing new technologies can revolutionize health care and help engage patients in their own care.

Technology and Patient Engagement

Technology and Patient Engagement

Using technology to engage patients with diabetes is important in the changing landscape of health information.

SGLT2 Inhibitors and Ketoacidosis Cases

SGLT2 Inhibitors and Ketoacidosis Cases

Jennifer N. Clements, PharmD, BPCS, CDE, BCACP, reviews some details of the reports of ketocacidosis with the use of SGLT2 inhibitors.

Type 1 Diabetes and Mortality Risk

Type 1 Diabetes and Mortality Risk

One study demonstrating increased mortality among patients with type 1 diabetes implicates the importance of glycemic control.

Pramlintide for Diabetes Care?

Pramlintide for Diabetes Care?

Reflections on the drug may raise questions about when to use pramlintide in diabetes.

Giving Up Power to Build Power

Giving Up Power to Build Power

Rajiv Narayan, MSc, offers his thoughts on the special series on obesity published in The Lancet and what changes are necessary to fight the disease.

Liraglutide as Saxenda for Obesity

Liraglutide as Saxenda for Obesity

Jennifer N. Clements, PharmD, BCPS, CDE, BCACP, discusses the pros and cons of liraglutide as a new therapy for weight management.

4 Questions to Consider When Treating Obesity

4 Questions to Consider When Treating Obesity

Clinicians should bear some concerns in mind when following the Endocrine Society's recommendations on pharmacological management of obesity.

Optimal Care for Thyroid Nodules

Optimal Care for Thyroid Nodules

Richard T. Kloos, MD, discusses new technologies and methods for diagnosis of thyroid nodules.

Top 10 Issues from Obesity Week

Top 10 Issues from Obesity Week

Rajiv Narayan, MSc, discusses the top 10 abstracts presented at Obesity Week 2014.

Acarbose May Pose Higher Cardiovascular Risk Than Metformin

Acarbose May Pose Higher Cardiovascular Risk Than Metformin

Robert W Lash, MD, of the Endocrine Society, finds this study interesting and useful, but not a stinging indictment of acarbose.

New Year, New Recommendations for Diabetes Care

New Year, New Recommendations for Diabetes Care

A new ADA and EASD position statement along with the ADA's revised Standards of Medical Care in Diabetes have surprising updates.

6 Misperceptions About Iodine Nutrition

6 Misperceptions About Iodine Nutrition

Adequate iodine nutrition is essential for production of thyroid hormones, but many patients harbor misperceptions about iodine intake.

Qsymia for Obese Diabetes Patients

Qsymia for Obese Diabetes Patients

Evidence shows that the maximum dose of Qsymia is effective for obese patients with type 2 diabetes, but clinicians should still consider all factors.

Biomedical Research Funding and Congress

Biomedical Research Funding and Congress

The Endocrine Society is urging Congress to address shrinking federal budgets that may hinder groundbreaking medical research.

Endocrine Disorders in Young Female Athletes

Endocrine Disorders in Young Female Athletes

Young female athletes my experience endocrine disorders, including menstrual problems and difficulty with bone mass, due to intense training.

Repeat Evaluation of Benign Thyroid Nodules

Repeat Evaluation of Benign Thyroid Nodules

Kenneth D. Burman, MD, discusses one study suggesting that the optimal time for repeat evaluation of benign thyroid nodules is 2 to 4 years.

Delving Deeper Into Lipids for Cardiovascular Risk Assessment

Delving Deeper Into Lipids for Cardiovascular Risk Assessment

The first step in reducing the risk for cardiovascular disease is for health care professionals to get a full understanding of a patient's risk.

Let's Talk About Menopause

Let's Talk About Menopause

The Menopause Map facilitates discussion between patients and providers on the "menopause journey."

Growth Hormone Use in Teens

Growth Hormone Use in Teens

Study showing increased GH use among teens may have inherent flaws.

Education Can Diminish Blow of Diabetes Diagnosis

Education Can Diminish Blow of Diabetes Diagnosis

Help patients direct their energy into positive behaviors to manage their diabetes.

Sign Up for Free e-Newsletters